Brief: Bioxcel Therapeutics Enters Fourteenth Amendment To Credit Agreement On August 24, 2026
25/08/2026 12:39
BRIEF-Bioxcel Therapeutics Enters Fourteenth Amendment To Credit Agreement On August 24, 2026 Aug 25 (Reuters) - BioXcel Therapeutics Inc BTAI.O:
BIOXCEL THERAPEUTICS - ENTERS FOURTEENTH AMENDMENT TO CREDIT AGREEMENT ON AUGUST 24, 2026 - SEC FILING
BIOXCEL THERAPEUTICS - LENDERS PROVIDE $1.25 MILLION IN ADDITIONAL LOANS UNDER AMENDMENT NO. 14 TERM LOANS - SEC FILING
Source text: [ID:n0001104659-26-100532]
Further company coverage: BTAI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioXcel Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Bleichroeder Acquisition Corp, Halliburton, BioNTech
U.S. STOCKS ON THE MOVE-Halliburton, BioNTech, Kazia Therapeutics
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna
Brief: Bioxcel Therapeutics Enters Into Asset Sale Agreement With Teva Pharmaceuticals
U.S. STOCKS ON THE MOVE-Cytokinetics, Moderna, Ulta Beauty